7 results
40-F
2011 FY
EX-99.63
THTX
Theratechnologies Inc.
13 Jun 11
Annual report (Canada)
12:00am
and sales. He became General Manager in Switzerland in 2007. During his tenure at Sanofi-Aventis (Sanofi-Synthélabo merged with Aventis in 2004) he held
40FR12B
EX-99.63
THTX
Theratechnologies Inc.
13 Jun 11
Initial registration of securities (Canada)
12:00am
and sales. He became General Manager in Switzerland in 2007. During his tenure at Sanofi-Aventis (Sanofi-Synthélabo merged with Aventis in 2004) he held
6-K
EX-99.1
THTX
Theratechnologies Inc.
29 Feb 24
Theratechnologies Announces the Resignation of One of Its
4:55pm
. “Alain was the current Chair of the Audit Committee and, during his tenure as a Board member, he was also a member of the Compensation Committee from May
40-F
2011 FY
EX-99.55
THTX
Theratechnologies Inc.
13 Jun 11
Annual report (Canada)
12:00am
. During his tenure at sanofi-aventis (Sanofi-Synthelabo merged with Aventis in 2004), he held positions in Germany, Canada, Switzerland and France. Mr
40FR12B
EX-99.55
THTX
Theratechnologies Inc.
13 Jun 11
Initial registration of securities (Canada)
12:00am
. During his tenure at sanofi-aventis (Sanofi-Synthelabo merged with Aventis in 2004), he held positions in Germany, Canada, Switzerland and France. Mr
6-K
EX-99.1
0yye5u
10 Sep 20
Theratechnologies to Develop Tesamorelin for the Treatment
12:48pm
40-F
EX-99.4
tylib7575 es
25 Feb 21
Annual report (Canada)
8:31am
- Prev
- 1
- Next